Top Markets
Coin of the day
Alliance Pharma plc Alliance Pharma plc

Alliance Pharma plc

APH
Rangering i aksjer #13761
Alliance Pharma plc is a pharmaceutical firm with an expansive global reach,... Alliance Pharma plc is a pharmaceutical firm with an expansive global reach, conducting business across Europe, the Middle East, Africa, the Asia Pacific region, China, and the Americas. The company's core activities involve sourcing, promoting, and distributing a diverse array of consumer healthcare items and prescribed medications. It currently manages the marketing rights for approximately 80 different products within these categories. Additionally, its offerings extend to medical devices, dietary supplements, and cosmetic goods. Notable brands within its portfolio include Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen. Founded in 1996, Alliance Pharma plc maintains its corporate base in Chippenham, United Kingdom.
Aksjekurs
$0.85814713
Sist synkronisert: 2025-05-14
Markedsverdi
$463.40M
Endring (1 dag)
-2.52%
Endring (1 år)
0.00%
Land
GB
Handel Alliance Pharma plc (APH)

Kategori

Inntekter for Alliance Pharma plc (APH)
Inntekter i Dec 2024 TTM: $224.41M
Ifølge de nyeste økonomiske rapportene til Alliance Pharma plc er selskapets nåværende inntekter (TTM) $224.41M. I 2023 hadde selskapet inntekter på $230.01M en økning sammenlignet med inntektene i 2022, som var $202.54M. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Alliance Pharma plc fra 2001 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $224.41M 0.00%
2024 $224.41M -2.43%
2023 $230.01M 13.56%
2022 $202.54M -8.21%
2021 $220.65M 24.34%
2020 $177.46M -1.34%
2019 $179.87M 19.46%
2018 $150.56M 7.84%
2017 $139.62M 16.04%
2016 $120.32M 68.90%
2015 $71.24M 5.03%
2014 $67.83M -10.01%
2013 $75.38M 3.50%
2012 $72.83M 2.12%
2011 $71.32M -8.14%
2010 $77.64M 53.57%
2009 $50.56M 59.16%
2008 $31.76M -12.52%
2007 $36.31M 7.34%
2006 $33.83M 60.14%
2005 $21.13M 9.03%
2004 $19.38M 44.44%
2002 $13.42M 51.66%
2001 $8.85M 0.00%
Inntekter for lignende selskaper eller konkurrenter